BALYASNY ASSET MANAGEMENT L.P.

Holdings History for Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Symbol: CTNM on Nasdaq
Investment type: Equity / Class A Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned: 2,312,800 shares
Security Ownership %: 7.6%

Shares, Excluding Options vs Price

Value, Excluding Options

Balyasny Asset Management L.P. ownership in Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM)

17 Feb 2026 - Balyasny Asset Management L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,312,800 shares of Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM). This represents 7.6% ownership of the company. This is the first filing by BALYASNY ASSET MANAGEMENT L.P. disclosing ownership of Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Balyasny Asset Management L.P.	7.6%		$26,435,304	2,312,800			$11.43	13G	31 Dec 2025	17 Feb 2026, 06:28

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.04%	+0.02%	$21,063,204	1,842,800	+891,480	+94%	$11.43	Q4 2025
30 Sep 2025		0.02%	+0.02%	$11,178,010	951,320	+951,320	NEW	$11.75	Q3 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.